FERRET-SEARCH Archives

Searchable FML archives

FERRET-SEARCH@LISTSERV.FERRETMAILINGLIST.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Vicki Montgomery <[log in to unmask]>
Date:
Thu, 6 Dec 2007 07:35:26 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (123 lines)
I have several pet's Microchipped. I hate to think that I've set them
up for malignant cancer..

Vicki

http://blog.wired.com/sterling/2007/11/arphid-watch-al.html

Arphid Watch: All the Cancer You Can Eat By Bruce Sterling November 22,
2007 | 8:26:07 AM

FOR IMMEDIATE RELEASE
November 19, 20007 [Yes, it really reads 20007. BIG]
CASPIAN RELEASES MICROCHIP CANCER REPORT

Sets record straight after misleading claims by HomeAgain and VeriChip
implant manufacturers

A new paper titled "Microchip-Induced Tumors in Laboratory Rodents and
Dogs: A Review of the Literature 1990–2006" has been released today
by CASPIAN. The full, 48-page paper provides a definitive review of
the academic literature showing a causal link between implanted
radio-frequency (RFID) microchip transponders and cancer in laboratory
rodents and dogs. In addition, a brief, four-page synopsis of the full
report is being made available.

Eleven articles previously published in toxicology and pathology
journals are evaluated in the report. In six of the articles, between
0.8% and 10.2% of laboratory mice and rats developed malignant tumors
around or adjacent to the microchips, and several researchers suggested
the actual tumor rate may have been higher. Two additional articles
reported microchip-related cancer in dogs.

In almost all cases, the malignant tumors, typically sarcomas, arose
at the site of the implants and grew to surround and fully encase the
devices. In several cases the tumors also metastasized or spread to
other parts of the animals.

Public revelation of a causal link between microchipping and cancer
in animals has prompted widespread public concern over the safety of
implantable microchips. The story was first broken to the public in
September through an article written by Associated Press Reporter Todd
Lewan. Prior to the AP story, the journal articles were completely
unknown outside of small academic circles.

"The AP did a superb job informing the public of the existence of these
journal articles," said Dr. Katherine Albrecht, a leading privacy
expert and long-time VeriChip opponent who authored the new paper.
"Unfortunately," Dr. Albrecht added, "a lot of misinformation about the
cancer research has circulated since Mr. Lewan's article was published.
I wrote the report to set the record straight."

The animal-microchip study findings were so compelling that one of
Mr. Lewan's sources, Dr. Robert Benezra, head of the Cancer Biology
Genetics Program at the Memorial Sloan-Kettering Cancer Center in New
York, was quoted as saying, "There's no way in the world, having read
this information, that I would have one of those chips implanted in my
skin, or in one of my family members."

Nevertheless, representatives of the chipping industry have made
inaccurate public statements about the research findings in an effort
to confuse the public.

Scott Silverman, CEO of the VeriChip Corporation which makes the
controversial VeriChip human implant, recently provided inaccurate
information to Time Magazine. Mr. Silverman is quoted as saying that
none of the tumors found in mice in a 2006 French study were malignant.
In fact, not only were the tumors malignant sarcomas, but most of the
afflicted animals died prematurely as a result of the
microchip-associated tumors.

In addition, Destron Fearing, makers of the HomeAgain pet implant,
dismissed a finding of fibrosarcoma--a highly lethal cancer--as
'benign' in a recent report.

A fibrosarcoma is a type of sarcoma, a malignant tumor of soft tissue
that connects, supports or surrounds other structures and organs of the
body. Dr. Timothy Jennings, an expert on implant-induced cancers in
humans, said he was "not aware of any nosology incorporating an entity
of 'benign fibrosarcoma'" and agreed that "any tumor classified as
sarcoma should be viewed as malignant."

"Either VeriChip and the makers of HomeAgain actually don't understand
the difference between a benign fibroma and a malignant fibrosarcoma,"
noted Dr. Albrecht, "or they're deliberately lying to the public.
Either way, it's clear they can't be trusted. We hope our new report
will set the record straight."

The report includes a one- to three-page writeup on each of the
original studies. In addition to a detailed review of the academic
literature, the report contains recommendations for patients, pet
owners, veterinarians, and policy makers, including the following:

(1) Further microchipping of humans should be immediately discontinued; 

(2) Implanted patients should be informed in writing of the research
    findings and offered a procedure for microchip removal; and

(3) Policy makers should reverse all animal microchipping mandates.

As part of its public awareness campaign, CASPIAN will be issuing
copies of the new report to leading policy and decision makers.

The full 48-page report and four-page synopsis are also immediately
available for public download at http://www.antichips.com/cancer/

  =======================================
ABOUT CASPIAN 
CASPIAN (Consumers Against Supermarket Privacy Invasion and Numbering)
is a grass-roots consumer group fighting retail surveillance schemes
since 1999 and irresponsible RFID use since 2002. With thousands of
members in all 50 U.S. states and over 30 countries worldwide, CASPIAN
seeks to educate consumers about marketing strategies that invade their
privacy and encourage privacy-conscious shopping habits across the
retail spectrum.
See: http://www.antichips.com 
http://www.spychips.com 
http://www.nocards.org 
FOR MORE INFORMATION OR TO ARRANGE AN INTERVIEW, PLEASE CONTACT:
Katherine Albrecht ([log in to unmask]) 877-287-5854 ext. 1

[Posted in FML 5813]


ATOM RSS1 RSS2